{"transactions":[{"id":854619,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Statutory Stock Option NQ","published_at":"2026-03-09T22:08:11.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":551500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":551500,"derivative":{"exercise_price":10.11,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":551500},"source":{"system":"sec-edgar","filing":"0001104659-26-025363","document":"tm268290-2_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926025363/tm268290-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":859557,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T11:03:17.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":150167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the \"Plan\") vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date."}],"balance_after":300333,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":150167},"source":{"system":"sec-edgar","filing":"0001104659-26-023726","document":"tm268076-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023726/tm268076-3_4seq1.xml","form_type":"4"}},{"id":859556,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-05T11:03:17.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":69288,"price":9.49,"value":657543.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":225680,"source":{"system":"sec-edgar","filing":"0001104659-26-023726","document":"tm268076-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023726/tm268076-3_4seq1.xml","form_type":"4"}},{"id":859555,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-05T11:03:17.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":150167,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":264130,"source":{"system":"sec-edgar","filing":"0001104659-26-023726","document":"tm268076-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023726/tm268076-3_4seq1.xml","form_type":"4"}},{"id":870566,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Statutory Stock Option NQ","published_at":"2026-03-04T02:37:04.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":551500,"price":9.09,"value":5013135.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":551500,"derivative":{"exercise_price":9.09,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":551500},"source":{"system":"sec-edgar","filing":"0001104659-26-023074","document":"tm267953-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023074/tm267953-4_4seq1.xml","form_type":"4"}},{"id":870565,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T02:37:04.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":367500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date."}],"balance_after":367500,"derivative":{"exercise_price":0,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":367500},"source":{"system":"sec-edgar","filing":"0001104659-26-023074","document":"tm267953-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023074/tm267953-4_4seq1.xml","form_type":"4"}},{"id":870564,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T02:37:04.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the \"Plan\") vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001104659-26-023074","document":"tm267953-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023074/tm267953-4_4seq1.xml","form_type":"4"}},{"id":870563,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T02:37:04.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":38450,"price":10.14,"value":389883.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":225680,"source":{"system":"sec-edgar","filing":"0001104659-26-023074","document":"tm267953-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023074/tm267953-4_4seq1.xml","form_type":"4"}},{"id":870562,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T02:37:04.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":264130,"source":{"system":"sec-edgar","filing":"0001104659-26-023074","document":"tm267953-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023074/tm267953-4_4seq1.xml","form_type":"4"}},{"id":931448,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-27T00:57:59.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":false,"shares":83197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":83197},"source":{"system":"sec-edgar","filing":"0001104659-26-006721","document":"tm264124-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926006721/tm264124-1_4seq1.xml","form_type":"4"}},{"id":931447,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-27T00:57:59.000Z","date":"2026-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":39132,"price":9.17,"value":358840.44,"ownership":{"direct":true},"balance_after":180797,"source":{"system":"sec-edgar","filing":"0001104659-26-006721","document":"tm264124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926006721/tm264124-1_4seq1.xml","form_type":"4"}},{"id":931446,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-27T00:57:59.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":true,"shares":83197,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":219929,"source":{"system":"sec-edgar","filing":"0001104659-26-006721","document":"tm264124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926006721/tm264124-1_4seq1.xml","form_type":"4"}},{"id":1224134,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"2025 Restricted Stock Units RSU","published_at":"2025-03-05T22:03:24.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":450500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":450500,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":450500},"source":{"system":"sec-edgar","filing":"0001593968-25-000304","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000304/primary_01.xml","form_type":"4"}},{"id":1224133,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"2025 Non-statutory Stock Option NQ","published_at":"2025-03-05T22:03:24.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":676000,"price":7.87,"value":5320120.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":676000,"derivative":{"exercise_price":7.87,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":676000},"source":{"system":"sec-edgar","filing":"0001593968-25-000304","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000304/primary_01.xml","form_type":"4"}},{"id":1231750,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T23:42:03.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":166666,"derivative":{"exercise_price":0,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001593968-25-000286","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000286/primary_01.xml","form_type":"4"}},{"id":1231749,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-04T23:42:03.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":38451,"price":8.33,"value":320296.83,"ownership":{"direct":true},"balance_after":136732,"source":{"system":"sec-edgar","filing":"0001593968-25-000286","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000286/primary_01.xml","form_type":"4"}},{"id":1231748,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-04T23:42:03.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":175183,"source":{"system":"sec-edgar","filing":"0001593968-25-000286","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000286/primary_01.xml","form_type":"4"}},{"id":1294787,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-27T23:19:02.000Z","date":"2025-01-23","kind":"exercise","planned":false,"acquired":false,"shares":83196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":83197,"derivative":{"exercise_price":0,"expiration_date":"2033-01-23","underlying":"Common Stock","underlying_shares":83196},"source":{"system":"sec-edgar","filing":"0001593968-25-000137","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000137/primary_01.xml","form_type":"4"}},{"id":1294786,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-27T23:19:02.000Z","date":"2025-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":38873,"price":9.55,"value":371237.15,"ownership":{"direct":true},"balance_after":91849,"source":{"system":"sec-edgar","filing":"0001593968-25-000137","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000137/primary_01.xml","form_type":"4"}},{"id":1294785,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-27T23:19:02.000Z","date":"2025-01-23","kind":"exercise","planned":false,"acquired":true,"shares":83196,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":130722,"source":{"system":"sec-edgar","filing":"0001593968-25-000137","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000137/primary_01.xml","form_type":"4"}},{"id":1561107,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T22:11:33.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-24-039129","document":"tm249879-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924039129/tm249879-3_4seq1.xml","form_type":"4"}},{"id":1561106,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-26T22:11:33.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on the first anniversary of the March 1, 2024 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":5.39,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-24-039129","document":"tm249879-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924039129/tm249879-3_4seq1.xml","form_type":"4"}},{"id":1671333,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-01-25T22:00:09.000Z","date":"2024-01-23","kind":"exercise","planned":false,"acquired":false,"shares":83197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the January 23, 2023 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the January 23, 2023 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":166393,"derivative":{"underlying":"Common Stock","underlying_shares":83197},"source":{"system":"sec-edgar","filing":"0001209191-24-002239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919124002239/doc4.xml","form_type":"4"}},{"id":1671332,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-25T22:00:09.000Z","date":"2024-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":40093,"price":4.26,"value":170796.18,"ownership":{"direct":true},"balance_after":43104,"source":{"system":"sec-edgar","filing":"0001209191-24-002239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919124002239/doc4.xml","form_type":"4"}},{"id":1671331,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-25T22:00:09.000Z","date":"2024-01-23","kind":"exercise","planned":false,"acquired":true,"shares":83197,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":83197,"source":{"system":"sec-edgar","filing":"0001209191-24-002239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919124002239/doc4.xml","form_type":"4"}},{"id":2046732,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-01-25T22:06:54.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":249590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":249590,"derivative":{"underlying":"Common Stock","underlying_shares":249590},"source":{"system":"sec-edgar","filing":"0001209191-23-004855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123004855/doc4.xml","form_type":"4"}},{"id":2046731,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2023-01-25T22:06:54.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":290700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") 2023 Inducement Plan (the \"Plan\") will vest on the first anniversary of the January 23, 2023 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":290700,"derivative":{"exercise_price":11.92,"exercise_date":"2024-01-23","expiration_date":"2033-01-23","underlying":"Common Stock","underlying_shares":290700},"source":{"system":"sec-edgar","filing":"0001209191-23-004855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123004855/doc4.xml","form_type":"4"}},{"id":2183522,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2022-08-16T20:04:29.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on October 1, 2018."}],"balance_after":114751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-22-008696","document":"form4-08162022_010808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008696/form4-08162022_010808.xml","form_type":"4"}},{"id":2183521,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2022-08-16T20:04:29.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":909,"price":51.7636,"value":47053.1124,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.56 to $52.05. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-008696","document":"form4-08162022_010808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008696/form4-08162022_010808.xml","form_type":"4"}},{"id":2183520,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2022-08-16T20:04:29.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":39091,"price":51.0542,"value":1995759.7322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.56 to $51.54. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":909,"source":{"system":"sec-edgar","filing":"0001415889-22-008696","document":"form4-08162022_010808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008696/form4-08162022_010808.xml","form_type":"4"}},{"id":2183519,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2022-08-16T20:04:29.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":40000,"price":8.22,"value":328800.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001415889-22-008696","document":"form4-08162022_010808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922008696/form4-08162022_010808.xml","form_type":"4"}},{"id":2229376,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2022-06-16T20:15:51.000Z","date":"2022-06-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on October 1, 2018."}],"balance_after":154751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-071909","document":"tm2218582-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071909/tm2218582-1_4seq1.xml","form_type":"4"}},{"id":2229375,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-06-16T20:15:51.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":800,"price":46.1337,"value":36906.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.19. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-071909","document":"tm2218582-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071909/tm2218582-1_4seq1.xml","form_type":"4"}},{"id":2229374,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-06-16T20:15:51.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":14200,"price":45.3782,"value":644370.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.78. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001104659-22-071909","document":"tm2218582-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071909/tm2218582-1_4seq1.xml","form_type":"4"}},{"id":2229373,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-06-16T20:15:51.000Z","date":"2022-06-15","kind":"exercise","acquired":true,"shares":15000,"price":8.22,"value":123300.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001104659-22-071909","document":"tm2218582-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071909/tm2218582-1_4seq1.xml","form_type":"4"}},{"id":2232158,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2022-06-14T20:16:08.000Z","date":"2022-06-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on October 1, 2018."}],"balance_after":169751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-071014","document":"tm2218405-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071014/tm2218405-1_4seq1.xml","form_type":"4"}},{"id":2232157,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-06-14T20:16:08.000Z","date":"2022-06-13","kind":"sale","acquired":false,"shares":15197,"price":44.5269,"value":676675.2993,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.02 to $44.89. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-071014","document":"tm2218405-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071014/tm2218405-1_4seq1.xml","form_type":"4"}},{"id":2232156,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-06-14T20:16:08.000Z","date":"2022-06-13","kind":"sale","acquired":false,"shares":9803,"price":43.6331,"value":427735.2793,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.02 to $44.01. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15197,"source":{"system":"sec-edgar","filing":"0001104659-22-071014","document":"tm2218405-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071014/tm2218405-1_4seq1.xml","form_type":"4"}},{"id":2232155,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-06-14T20:16:08.000Z","date":"2022-06-13","kind":"exercise","acquired":true,"shares":25000,"price":8.22,"value":205500.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-22-071014","document":"tm2218405-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922071014/tm2218405-1_4seq1.xml","form_type":"4"}},{"id":2323880,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2022-03-18T20:23:39.000Z","date":"2022-03-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on October 1, 2018."}],"balance_after":194751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-035613","document":"tm228148-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922035613/tm228148-5_4seq1.xml","form_type":"4"}},{"id":2323879,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-03-18T20:23:39.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":15000,"price":45.3214,"value":679821.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.66. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-035613","document":"tm228148-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922035613/tm228148-5_4seq1.xml","form_type":"4"}},{"id":2323878,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-03-18T20:23:39.000Z","date":"2022-03-16","kind":"exercise","acquired":true,"shares":15000,"price":8.22,"value":123300.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001104659-22-035613","document":"tm228148-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922035613/tm228148-5_4seq1.xml","form_type":"4"}},{"id":2330096,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2022-03-16T20:05:46.000Z","date":"2022-03-14","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in five equal annual installments beginning on October 1, 2018."}],"balance_after":209751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-034442","document":"tm228148-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922034442/tm228148-4_4seq1.xml","form_type":"4"}},{"id":2330095,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-03-16T20:05:46.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":930,"price":43.47,"value":40427.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.35 to $43.77. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-034442","document":"tm228148-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922034442/tm228148-4_4seq1.xml","form_type":"4"}},{"id":2330094,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-03-16T20:05:46.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":11614,"price":42.6618,"value":495474.1452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.34 to $43.33. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":930,"source":{"system":"sec-edgar","filing":"0001104659-22-034442","document":"tm228148-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922034442/tm228148-4_4seq1.xml","form_type":"4"}},{"id":2330093,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-03-16T20:05:46.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":12456,"price":42.0577,"value":523870.7112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.34 to $42.33. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12544,"source":{"system":"sec-edgar","filing":"0001104659-22-034442","document":"tm228148-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922034442/tm228148-4_4seq1.xml","form_type":"4"}},{"id":2330092,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-03-16T20:05:46.000Z","date":"2022-03-14","kind":"exercise","acquired":true,"shares":25000,"price":8.22,"value":205500.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-22-034442","document":"tm228148-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922034442/tm228148-4_4seq1.xml","form_type":"4"}},{"id":2442522,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2022-01-05T21:15:55.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":18053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 251,801 shares, and will vest with respect to the remainder of the shares on October 1, 2022."}],"balance_after":234751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":18053},"source":{"system":"sec-edgar","filing":"0001104659-22-001475","document":"tm221863-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922001475/tm221863-1_4seq1.xml","form_type":"4"}},{"id":2442521,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2022-01-05T21:15:55.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":10647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 251,801 shares, and will vest with respect to the remainder of the shares on October 1, 2022."}],"balance_after":252804,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":10647},"source":{"system":"sec-edgar","filing":"0001104659-22-001475","document":"tm221863-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922001475/tm221863-1_4seq1.xml","form_type":"4"}},{"id":2442520,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-01-05T21:15:55.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":18053,"price":45.1476,"value":815049.6228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.70. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-001475","document":"tm221863-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922001475/tm221863-1_4seq1.xml","form_type":"4"}},{"id":2442519,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-01-05T21:15:55.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":18053,"price":8.22,"value":148395.66,"ownership":{"direct":true},"balance_after":18053,"source":{"system":"sec-edgar","filing":"0001104659-22-001475","document":"tm221863-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922001475/tm221863-1_4seq1.xml","form_type":"4"}},{"id":2442518,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-01-05T21:15:55.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":10647,"price":45.171,"value":480935.637,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.37. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-001475","document":"tm221863-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922001475/tm221863-1_4seq1.xml","form_type":"4"}},{"id":2442517,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-01-05T21:15:55.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":10647,"price":8.22,"value":87518.34,"ownership":{"direct":true},"balance_after":10647,"source":{"system":"sec-edgar","filing":"0001104659-22-001475","document":"tm221863-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465922001475/tm221863-1_4seq1.xml","form_type":"4"}},{"id":2456714,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2021-12-29T21:18:11.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is currently vested with respect to 251,801 shares, and will vest with respect to the remainder of the shares on October 1, 2022."}],"balance_after":263451,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001104659-21-154289","document":"tm2135185-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465921154289/tm2135185-4_4seq1.xml","form_type":"4"}},{"id":2456713,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-29T21:18:11.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":1300,"price":45.0296,"value":58538.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.15. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-154289","document":"tm2135185-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465921154289/tm2135185-4_4seq1.xml","form_type":"4"}},{"id":2456712,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-29T21:18:11.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":1300,"price":8.22,"value":10686.0,"ownership":{"direct":true},"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001104659-21-154289","document":"tm2135185-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465921154289/tm2135185-4_4seq1.xml","form_type":"4"}},{"id":2471094,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2021-12-16T01:22:12.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 251,801 shares, and will vest with respect to the remainder of the shares on October 1, 2022."}],"balance_after":264751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-150129","document":"tm2135185-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465921150129/tm2135185-2_4seq1.xml","form_type":"4"}},{"id":2471093,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-16T01:22:12.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":11860,"price":38.43,"value":455779.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.20 to $38.69. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-150129","document":"tm2135185-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465921150129/tm2135185-2_4seq1.xml","form_type":"4"}},{"id":2471092,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-16T01:22:12.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":13140,"price":38.0235,"value":499628.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.20 to $38.19. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11860,"source":{"system":"sec-edgar","filing":"0001104659-21-150129","document":"tm2135185-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465921150129/tm2135185-2_4seq1.xml","form_type":"4"}},{"id":2471091,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-16T01:22:12.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":25000,"price":8.22,"value":205500.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-21-150129","document":"tm2135185-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465921150129/tm2135185-2_4seq1.xml","form_type":"4"}},{"id":2570290,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2021-09-14T22:45:49.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is currently vested with respect to 188,851 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 1, 2021."}],"balance_after":289751,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-035891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035891/doc4.xml","form_type":"4"}},{"id":2570289,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-09-14T22:45:49.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":25000,"price":35.9305,"value":898262.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.45 to $36.38. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-035891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035891/doc4.xml","form_type":"4"}},{"id":2570288,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-09-14T22:45:49.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":25000,"price":8.22,"value":205500.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000899243-21-035891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924321035891/doc4.xml","form_type":"4"}},{"id":3050615,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":62128,"kind":"person","name":"Jacobs John C","position":1,"cik":"0001820836","reported_name":"Jacobs John C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2020-08-21T00:13:12.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":144856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in five equal annual installments beginning on August 21, 2021."}],"balance_after":144856,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":144856},"source":{"system":"sec-edgar","filing":"0000899243-20-023136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023136/doc4.xml","form_type":"4"}}]}